Kanyos Bio, Inc. — Form D
Kanyos Bio, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-06-12. The offering totals $10.4M, of which $10.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-06-12
- Form: D
- Accession: 0001644743-15-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.4M
- Amount sold: $10.4M
- Investors: 16
- Date of first sale: 2015-05-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-241682
Issuer
- Name: Kanyos Bio, Inc.
- CIK: 0001644743
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: ONE SANSOME STREET, SUITE 3630, SAN FRANCISCO, CA, 94104
- Phone: 312-972-6001
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Thomas Woiwode | Director | San Francisco, CA |
| Jack Nielsen | Director | Palo Alto, CA |
| Jeffrey Hubbell | Director | Chicago, IL |
| Jeffrey Hubbell | Executive Officer | Chicago, IL |
| Florent Gros | Director | Menlo Park, CA |
| Oscar Buset | Executive Officer | SAN FRANCISCO, CA |
| Harry Welten | Director | SAN FRANCISCO, CA |
| Andre Mueller | Director | SAN FRANCISCO, CA |
Other filings by this issuer (1)
More